| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/27/2013 | CN102940639A Application of indometacin2-aryl morpholine ethyl ester in preparing medicine capable of resisting breast cancer |
| 02/27/2013 | CN102940638A Administration of dipeptidyl peptidase inhibitors |
| 02/27/2013 | CN102940637A Isoniazid-rifampicin-anethol trithione composition and its oral preparation |
| 02/27/2013 | CN102940636A Injection of piperacillin-sulbactum sodium medicine composition and preparation method thereof |
| 02/27/2013 | CN102940635A Breast cancer resistant application of indenoisoquinoline vascular endothelial cell growth factor-2 receptor antagonist |
| 02/27/2013 | CN102940634A Isoniazid-anethol trithione composition and its oral preparation |
| 02/27/2013 | CN102940633A Flupirtine preparation for treating neurodegenerative disorders of the visual system and diabetes mellitus |
| 02/27/2013 | CN102940632A Application of FK506-A compound in preparation of immunosuppressant |
| 02/27/2013 | CN102940631A Application of Blebbistatin in promoting stem cell survival and keeping stem cell dry |
| 02/27/2013 | CN102940630A Medicinal composition containing temsirolimus and preparation method of medicinal composition |
| 02/27/2013 | CN102940629A New use of Tubacin |
| 02/27/2013 | CN102940628A Compound amino acid injection and preparation method thereof |
| 02/27/2013 | CN102940627A Method of treating polycystic kidney diseases with ceramide derivatives |
| 02/27/2013 | CN102940626A Applications of Eryngiolide A in anti-herpes virus drugs |
| 02/27/2013 | CN102940625A Applications of Eryngiolide A in platelet increase drugs |
| 02/27/2013 | CN102940624A Application of procyanidine in preparation of medicament for treating diabetes |
| 02/27/2013 | CN102940623A Medicinal composition of levocarnitine compound |
| 02/27/2013 | CN102940622A 腹膜透析液 Peritoneal dialysate |
| 02/27/2013 | CN102940621A Application of methyl ferulic acid in preparation of medicine for preventing and curing hepatic fibrosis |
| 02/27/2013 | CN102940620A Dietary and pharmaceutical compositions containing tricyclic diterpenes and their derivates and their uses |
| 02/27/2013 | CN102940619A Trans-clomiphene for metabolic syndrome |
| 02/27/2013 | CN102940618A Loxoprofen organic amine salt transdermal patch and preparation method thereof |
| 02/27/2013 | CN102940617A Desloratadine oral dispersible film |
| 02/27/2013 | CN102940616A Ambroxol hydrochloride oral cavity dispersion membrane agent |
| 02/27/2013 | CN102940615A Erythromycin enteric-coated tablets and preparation method thereof |
| 02/27/2013 | CN102940614A Method for preparing bulleyaconitine-containing tablets |
| 02/27/2013 | CN102940613A Low flush niacin formulation |
| 02/27/2013 | CN102940612A Method for preparing norfloxacin tablets |
| 02/27/2013 | CN102940611A Esomeprazole magnesium contained enteric-coated tablet and preparation method thereof |
| 02/27/2013 | CN102940610A Vitamin B6 composition freeze-drying orally disintegrating tablets and preparation method thereof |
| 02/27/2013 | CN102940608A Tripterine controlled-release solid dispersion |
| 02/27/2013 | CN102940607A Injection of piperacillin-sulbactum sodium medicine composition injection and preparation method thereof |
| 02/27/2013 | CN102940605A Piribedil sustained release preparation and preparation method thereof |
| 02/27/2013 | CN102940602A Essence powder for body care |
| 02/27/2013 | CN102939976A Disinfection isolating agent for silkworm bodies and silkworm rearing beds of silkworm breeding with artificial diet and application thereof |
| 02/27/2013 | CN102552592B Application of analgesic anti-inflammatory ointment in preparing medicine for treating carotid artery arteriosclerosis cerebral infarction |
| 02/27/2013 | CN102552591B Application of pain-relief anti-inflammation ointment to curing cerebral edema of contusion and laceration of brain |
| 02/27/2013 | CN102416015B Composition containing statins and application thereof |
| 02/27/2013 | CN102379867B Use of chicoric acid in treatment of fundus lesion |
| 02/27/2013 | CN102379856B Omeprazole-containing enteric coated tablets |
| 02/27/2013 | CN102351859B Antibiotic Pseudonocardian A and Pseudonocardian B, its preparation method thereof and its application in preparation of antibiotics and antitumor drug |
| 02/27/2013 | CN102319323B Eyedrop for reducing intraocular pressure and treating glaucoma and preparation method thereof |
| 02/27/2013 | CN102302450B Hydrophobic drug-albumin-glucan nano emulsion, as well as preparation method and application thereof |
| 02/27/2013 | CN102267966B Substituted benzopyrone derivatives and application thereof |
| 02/27/2013 | CN102266282B Micro/nanometer fiber slow release preparation for treating cicatrices and preparation method thereof |
| 02/27/2013 | CN102258585B Traditional Chinese medicine for treating hemorrhoids |
| 02/27/2013 | CN102258478B Animal pefloxacin mesylate pellets, and preparation method thereof |
| 02/27/2013 | CN102228597B Medicament for treating oral ulcer and preparation method |
| 02/27/2013 | CN102218048B Application of magnolol in preparation of external preparations and daily chemical products for treating dermatosis caused by malassezia |
| 02/27/2013 | CN102204914B Use of 4-alkyl-6-aryl-5-acetyl-1,3-thiazine for preparing neuraminidase inhibitor |
| 02/27/2013 | CN102198091B Acupuncture point injection |
| 02/27/2013 | CN102188363B Transdermal medicament delivery system containing donepezil compound, preparation and preparation method |
| 02/27/2013 | CN102168119B Method for preparing diaporthein B and application of diaporthein B to preparation of antitumor medicaments |
| 02/27/2013 | CN102167685B 4-(2'-n-butyl-4,5-disubstituted-2,4'-bis-imidazole-3'-methyl) benzoic acid derivative |
| 02/27/2013 | CN102153666B Sipunculidae polysaccharide and preparation method thereof and application thereof to anti-fatigue function |
| 02/27/2013 | CN102153533B 3-nitro-2H-chromene compounds with antibacterial activity and preparation method and application thereof |
| 02/27/2013 | CN102153515B N,N'-bis-substituted urea Raf kinase inhibitors and preparation method and application thereof |
| 02/27/2013 | CN102144981B Gemcitabine hydrochloride lyophilized powder injection and preparation method thereof |
| 02/27/2013 | CN102134188B Tetrahydroanthraquinone compound Prisconnatacin and preparation method and application thereof in preparation of anti-tumor medicaments |
| 02/27/2013 | CN102115429B (E)-1-(3,5-dimethoxyphenyl)-2-(3,5-dihydroxy-4-methoxyphenyl)ethylene, and preparation method and application thereof |
| 02/27/2013 | CN102101878B Hellebore petunidin space isomer compound and preparation and application thereof |
| 02/27/2013 | CN102085356B Composition for increasing bone mineral density and preparation method thereof |
| 02/27/2013 | CN102080083B Human miR-149 antisense nucleotide and application thereof |
| 02/27/2013 | CN102036662B Method for preventing and treating conditions mediated by PPAR using macelignan |
| 02/27/2013 | CN102002035B Delta and epsilon crystal forms of imatinib mesylate |
| 02/27/2013 | CN101977600B Protopanaxadiol-type ginsenoside compositions and uses thereof |
| 02/27/2013 | CN101959884B Derivatives of 6-heterocyclic-imidazo[l,2-alpha]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 02/27/2013 | CN101948549B Sulphating modification method of gynostemma pentaphylla polysaccharide |
| 02/27/2013 | CN101928246B N-[(1-aryl-3-substituted phenyl-pyrazol-4-yl) methenyl]-2-hydroxyl benzoyl hydrazine compound or pharmaceutically acceptable salts and preparation method thereof |
| 02/27/2013 | CN101918410B Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| 02/27/2013 | CN101918359B Sulfonamides as orexin antagonists |
| 02/27/2013 | CN101888846B Stable bicarbonate ion-containing drug solution |
| 02/27/2013 | CN101883589B Pharmaceutical compositon for cleansing of the bowel |
| 02/27/2013 | CN101869576B New application of fig polysaccharide |
| 02/27/2013 | CN101827828B 1, 2, 4 -triazole derivatives as serotonergic modulators |
| 02/27/2013 | CN101824033B Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 02/27/2013 | CN101820867B Solid valsartan composition |
| 02/27/2013 | CN101804034B Rabeprazole sodium powder injection and preparation method thereof |
| 02/27/2013 | CN101798317B N-substituted aminothiazole morphinan compound and preparation method and applications thereof |
| 02/27/2013 | CN101790533B Cyclopropyl fused indolobenzazepine hcv inhibitors |
| 02/27/2013 | CN101785853B Mesenchymal stem cell biological winkle removing agent and preparation method thereof |
| 02/27/2013 | CN101766608B Compound pseudoephedrine hydrochloride slow release preparation and preparing method thereof |
| 02/27/2013 | CN101759628B Ethynylindole compounds |
| 02/27/2013 | CN101757150B Application of traditional Chinese medicine composition in preparation of medicines for inhibiting carotid intimal-medial thickening |
| 02/27/2013 | CN101757073B Medicinal composition containing atractylodes rhizome extractive |
| 02/27/2013 | CN101732467B Application of Chinese medicinal composition in preparation of medicament for treating purulent pleurisy |
| 02/27/2013 | CN101716157B Metoprolol oral drug composite and preparation method thereof |
| 02/27/2013 | CN101687851B Organic compounds |
| 02/27/2013 | CN101665527B Ginsenoside, preparation method thereof and use thereof |
| 02/27/2013 | CN101653488B Application of Chinese medicinal composition in preparation of medicament for resisting myocardial stunning |
| 02/27/2013 | CN101653487B Application of Chinese medicinal composition in preparation of medicament for treating acute cerebral infarction |
| 02/27/2013 | CN101626762B Solvating system and sealant for medical use |
| 02/27/2013 | CN101623278B Medicinal composition containing levodopa and benserazide hydrochloride |
| 02/27/2013 | CN101623250B Levetiracetam medicinal composition and preparation method thereof |
| 02/27/2013 | CN101622229B Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 02/27/2013 | CN101553474B Imidazolone and imidazolidinone derivatives as 11b-HSD1 inhibitors for diabetes |
| 02/27/2013 | CN101532994B A method for measuring the content of a brain-invigorating and kidney-tonifying preparation |
| 02/27/2013 | CN101522683B Pyraz0l0(l,5-A) (1, 3, 5) triazine and pyrazolo (1, 5-A) pyrimidine derivatives useful as protein kinase inhibitors |
| 02/27/2013 | CN101511800B Triazolyl phenyl benzenesulfonamides |
| 02/27/2013 | CN101486659B Alpha 1-adrenalin receptor antagonist, and preparation and medical use thereof |